<乌鸦传媒>Modest Risks Come With Moving Fast on HF Drugs After Acute Event STRONG-HF analysis details the impact Oct 10, 2023
<乌鸦传媒>Risk of Contrast Media Causing Acute Kidney Injury Is Overblown, Study Finds Despite restrictions on its use, an association with kidney injury hasn't been shown Oct 10, 2023
<乌鸦传媒>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<乌鸦传媒>Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
<乌鸦传媒>CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<乌鸦传媒>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<乌鸦传媒>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<乌鸦传媒>Adherence Matters for CVD Secondary Prevention in CPAP Users Questionable benefit may hinge on number of hours used Oct 05, 2023
<乌鸦传媒>Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
<乌鸦传媒>Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<乌鸦传媒>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<乌鸦传媒>Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failure Mortality predicted by cumulative hsCRP levels over time Oct 02, 2023
<乌鸦传媒>FDA OKs Another Injectable for Rare Kidney Disorder Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
<乌鸦传媒>FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<乌鸦传媒>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and聽similar risk versus GLP-1 receptor agonists Sep 26, 2023
<乌鸦传媒>FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
<乌鸦传媒>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
<乌鸦传媒>Reassuring Registry Data on Going Into TAVR Sans Symptoms Would intervention beat watchful waiting for asymptomatic patients with severe aortic stenosis? Sep 20, 2023
<乌鸦传媒>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<乌鸦传媒>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Say Privacy policies, terms of sale often are unclear Sep 18, 2023
<乌鸦传媒>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<乌鸦传媒>No Avoiding Mitral Valve Implant Obstruction With Preemptive Ablation LVOT obstruction remains thorn in the side of TMVI in small case series Sep 15, 2023
<乌鸦传媒>Fresh Blood Not Always the Best Blood? French study assesses red blood cell transfusions and kidney transplant outcomes Sep 14, 2023
<乌鸦传媒>FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy Clinical meaningfulness is a different question, however Sep 13, 2023
<乌鸦传媒>Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortage Health news and commentary from around the Web gathered by 乌鸦传媒 staff Sep 12, 2023
<乌鸦传媒>One PrEP Regimen Linked to Higher Risk of Hypertension, Statin Use Over Another Use of TAF associated with increased risks within 2 years versus TDF, retrospective study finds Sep 11, 2023
<乌鸦传媒>When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat? "This is not your grandmother's heat," says policy expert Sep 10, 2023
<乌鸦传媒>Lorundrostat Stands a Chance Against Obesity-Related Hypertension Selective aldosterone synthase inhibitor proceeds to phase III study after Target-HTN's success Sep 10, 2023
<乌鸦传媒>Optimal BP After Stroke; Psilocybin for Depression Also in TTHealthWatch: culprit vessel or complete revascularization? Sep 09, 2023 podcast
<乌鸦传媒>New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
<乌鸦传媒>Calcium Channel Blockers Again Linked to Glaucoma But researcher says there's no need to switch most users to other antihypertensive drugs Sep 07, 2023
<乌鸦传媒>Low-Dose Semaglutide Can Ease Insulin Need in Early T1D, Small Series Shows All 10 patients were able to eliminate prandial insulin use within 3 months Sep 06, 2023
<乌鸦传媒>Predicting ICU Outcomes; Post-Stroke Brain Stimulation Also in TTHealthWatch: effect of frailty on intensive blood pressure control Sep 02, 2023 podcast
<乌鸦传媒>Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement" Aug 29, 2023
<乌鸦传媒>'Big Win' for Anti-Obesity Medication in Heart Failure Semaglutide led to meaningful reductions in symptoms, weight in patients with obesity and HFpEF Aug 29, 2023 video
<乌鸦传媒>U.S. Unveils First 10 Drugs for Medicare Price Negotiations Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
<乌鸦传媒>Compound in Beetroot Juice Fends Off Contrast-Induced AKI "Provocative" results for inorganic nitrate pill shown in NITRATE-CIN trial Aug 29, 2023
<乌鸦传媒>Case Grows for SGLT2 Inhibitors as Gout Treatment Large cohort study shows expansive benefits Aug 28, 2023
<乌鸦传媒>Afib Ablation Exceeds Expectations in Sickest Heart Failure Patients Death and surgeries delayed in end-stage heart failure Aug 28, 2023
<乌鸦传媒>CRT-D Upgrade Suits Patients With Pacing-Related Heart Failure BUDAPEST-CRT Upgrade is the first major trial on upgrade strategy Aug 27, 2023
